Hetero gets DCGI nod to launch biosimilar version of Tocilizumab
Hetero’s Tocilizumab 400mg/20ml is the biosimilar version of Roche’s Actemra/RoActemra drug. Tocilizumab is distributed by Cipla in India under licence from Roche. (Representational image) The Drug Controller General of India (DCGI) has granted Emergency Use Authorization (EUA) to Hetero for launching a biosimilar version of Tocilizumab, a Covid-19 drug for hospitalised adults. The Hyderabad-based company … Read more